Biology Reference
In-Depth Information
Poli G, Kinter AL, Fauci AS. 1994. Interleukin 1 induces expression of the human immuno-
de®ciency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibi-
tion of inductive e¨ects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 91;
108±112.
Pomerantz RJ, Trono D, Feinberg MB, Baltimore D. 1990. Cells nonproductively infected with
HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell
61; 1271±1276.
Radovanovic J, Todorovic V, Boricic I, Jankovic Hladni M, Korac A. 1999. Comparative ultra-
structural studies on mitochondrial pathology in the liver of AIDS patients: clusters of mi-
tochondria, protuberances, ``minimitochondria,'' vacuoles, and virus-like particles. Ultrastruct
Pathol 23; 19±24.
Reers M, Smith TW, Chen LB. 1991. J-aggregate formation of a carbocyanine as a quantitative
¯uorescent indicator of membrane potential. Biochemistry 30; 4480±4486.
Richter C, Schweizer M, Cossarizza A, Franceschi C. 1996. Control of apoptosis by the cellular
ATP level. FEBS Lett 378; 107±110.
Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. 1997. JC-1, but not DiOC
6
(3) or rhodamine
123, is a reliable ¯uorescent probe to assess DC in intact cells. Implications for studies on mi-
tochondrial functionality during apoptosis. FEBS Lett 411; 77±82.
Salvioli S, Barbi C, Dobrucki J, Troiano L, Moretti L, Pinti M, Pedrazzi J, Pazienza TL, Bobyleva
V, Franceschi C, Cossarizza A. 2000a. Opposite role of changes in mitochondrial membrane
potential (Dc) in di¨erent apoptotic processes. FEBS Lett 469; 186±190.
Salvioli S, Dobrucki J, Moretti L, Troiano L, Garcia Fernandez M, Pinti M, Pedrazzi J, Franceschi
C, Cossarizza A. 2000b. Mitochondrial heterogeneity during staurosporine-induced apoptosis in
HL60 cells: analysis at the single cell and single organelle level. Cytometry 40; 189±197.
Schlame M, Hostetler KY. 1997. Cardiolipin synthase from mammalian mitochondria. Biochim
Biophy Acta 1348; 207±213.
Sen S, D'Incalci M. 1992. Apoptosis. Biochemical events and relevance to cancer chemotherapy.
FEBS Lett 307; 122±127.
Shenker BJ, Guo TL, Shapiro IM. 1999. Induction of apoptosis in human T-cells by methyl mer-
cury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve.
Toxicol Appl Pharmacol 157; 23±35.
Shikuma C, Hu N, Milne C, Yost F, Shimizu S, Shiramizu B. 2001. Analysis of subcutaneous adi-
pose tissue mitochondrial DNA from individuals with HAART-associated lipodystrophy. In:
Eighth Conference on Retroviruses and Opportunistic Infections (Abs. 665). Chicago, Foundation
for Retrovirology and Human Health. ISBN 0-9669768-2-7.
Skulachev VP. 1996. Why are mitochondria involved in apoptosis? Permeability transition pores
and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell.
FEBS Lett 397; 7±10.
Skulachev VP. 1998. Uncoupling: new approaches to an old problem of bioenergetics. Biochim
Biophys Acta 1363; 100±124.
Skulachev VP. 2000. Mitochondria in the programmed cell death phenomena; a principle of Biol-
ogy: ``It is better to dye than to be wrong.'' IUBMB Life 49; 365±373.
Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, Chen LB. 1991.
Intracellular heterogeneity in mitochondrial membrane potential revealed by a J-aggregate-
forming lipophilic cation JC-1. Proc Natl Acad Sci USA 88; 3671±3675.
Somasundaran M, Zapp ML, Beattie LK, Pang L, Byron KS, Bassell GJ, Sullivan JL, Singer RH.
1994. Localization of HIV RNA in mitochondria of infected cells: potential role in cytopatho-
genicity. J Cell Biol 126; 1353±1360.
Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M,
Kroemer G. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp
Med 184; 1331±1341.
